A randomized, single-centre, open-label, three-way crossover, single-dose, phase I trial comparing two different dose strengths of a cebranopadol tablet formulation with a cebranopadol oral solution in the fasted state

A randomized, single-centre, open-label, three-way crossover, single-dose, phase I trial comparing two different dose strengths of a cebranopadol tablet formulation with a cebranopadol oral solution in the fasted state